Lateral Flow Assays Market worth $13.52 billion by 2031
The report "Lateral Flow Assays Market by Product (Kits, Readers), Application (HIV, HPV, TB, Cardiac Marker, Pregnancy, Hepatitis, Food Safety), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User (Hospitals), Region - Global Forecast to 2031" is expected to grow from USD 9.14 billion in 2026 to USD 13.52 billion by 2031 with a CAGR of 8.1%.
Browse 608 market data Tables and 57 Figures spread through 436 Pages and in-depth TOC on "Lateral Flow Assays Market, By Product (Kits, Readers), Application (HIV, HPV, TB, Cardiac Marker, Pregnancy, Hepatitis, Food Safety), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User (Hospitals), Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/lateral-flow-assay-market-167205133.html
The global lateral flow assay (LFA) market is propelled by several key factors such as the escalating prevalence of infectious diseases worldwide, growth in the aging population with rising chronic health needs, increased consumer adoption of user-friendly home‑based testing kits, and the expanding deployment of point-of-care (POC) diagnostics in clinics, pharmacies, and remote health facilities. However, the market also faces significant constraints: although LFAs offer rapid, cost-effective solutions, their sensitivity and specificity often trail molecular and lab-based methods, resulting in occasional false positives or negatives that can undermine clinical confidence.
By technique, the sandwich assays segment is expected to grow at the fastest rate in the lateral flow assay kits & reagents market across the forecast period.
Based on technique, the lateral flow assay kits and reagents market is segmented into competitive, sandwich, and multiplex detection assays. Sandwich assays dominated the market, with a share in 2025. This segment's large share is attributed to the better assay sensitivity and specificity of sandwich assays and their extensive use in measuring critical analytes (such as cardiac and hepatitis markers).
By sample type, blood samples held the largest share in the lateral flow assays market in 2025.
Based on sample type, the lateral flow assays market is segmented into blood, urine, saliva, and other samples (nasal swabs, throat swabs, and vaginal fluid). Blood samples accounted for the largest market share in 2025. The extensive use of blood samples in lateral flow tests and the easy detection of disease antibodies in blood samples are key factors driving growth in this market segment.
North America dominated the global lateral flow assays market in 2025.
The lateral flow assays market is segmented into six major segments, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries. North America accounts for the largest market share in the lateral flow assays market in 2025. North America leads the lateral flow assays market due to its advanced healthcare infrastructure and significant investments in medical technology innovation. Major medical device manufacturers and the growing evolution of LFA are driving growth, with advances in smartphone-enabled readers, AI-powered result interpretation, and multiplex testing formats.
Key Players
Prominent players in the lateral flow assays market include Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Becton, Dickinson and Company (US), QuidelOrtho Corporation (US), Siemens AG (Germany), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (US), Revvity, Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Merck KGaA (Germany), Surmodics, Inc. (US), and OraSure Technologies Inc. (US), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Lateral Flow Assays Market
- What will your New Revenue Sources be
- Who will be your Top Customer; what will make them switch
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
